Identification of KKL-35 as a novel carnosine dipeptidase 2 (CNDP2) inhibitor by in silico screening
Takujiro Homma, Koki Shinbara, Tsukasa Osaki
This study identifies KKL-35 as a novel CNDP2 inhibitor through in silico screening, showing it has favorable drug-like properties despite lower potency than bestatin.
bioRxiv · Sep 27, 2025 · PreprintBioinformatics